UBS AM’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-21,823
| Closed | -$132K | – | 2802 |
|
|
2024
Q2 | $132K | Buy |
+21,823
| New | +$132K | ﹤0.01% | 2770 |
|
|
2023
Q3 | – | Sell |
-11,581
| Closed | -$52.3K | – | 2592 |
|
|
2023
Q2 | $52.3K | Hold |
11,581
| – | – | ﹤0.01% | 2661 |
|
|
2023
Q1 | $52.3K | Buy |
+11,581
| New | +$52.3K | ﹤0.01% | 2661 |
|
|
2022
Q3 | – | Sell |
-13,251
| Closed | -$107K | – | 2740 |
|
|
2022
Q2 | $107K | Sell |
13,251
-352,402
| -96% | -$2.85M | ﹤0.01% | 2643 |
|
|
2022
Q1 | $6.18M | Buy |
365,653
+13,401
| +4% | +$226K | ﹤0.01% | 1265 |
|
|
2021
Q4 | $7.57M | Buy |
352,252
+79,915
| +29% | +$1.72M | ﹤0.01% | 1231 |
|
|
2021
Q3 | $20.1M | Sell |
272,337
-3,796
| -1% | -$280K | 0.01% | 865 |
|
|
2021
Q2 | $15.1M | Buy |
276,133
+93,273
| +51% | +$5.1M | 0.01% | 971 |
|
|
2021
Q1 | $13.5M | Buy |
182,860
+149,651
| +451% | +$11M | 0.01% | 981 |
|
|
2020
Q4 | $2.86M | Buy |
+33,209
| New | +$2.86M | ﹤0.01% | 1540 |
|